The drugs that are advertised most on TV are also the least effective, according to a major analysis.
Johns Hopkins University researchers found that spending on promoting prescription drugs rose from $1.3 billion in 1996 to $6 billion in 2016. Ninety-two of 135 drugs included in the study, or nearly 70 percent, were deemed to have little health benefits.
Dr Michael DiStefano, the lead author of the study, said: ‘The findings suggest that shifting promotional dollars to direct-to-consumer advertising potentially reflects a strategy to drive patient demand for drugs that clinicians would be less likely to prescribe.’
‘When a consumer sees these advertisements on TV or social media, they should really question if it’s the best drug for them and have a conversation with their provider.’
The findings come amid lingering ethical questions regarding TV drug advertising and come just weeks after a Harvard study found a similar discrepancy between the amount spent on medical adverts and the benefit the medicines provide to patients.